InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Eckhardt Sue Gail, Director. Officer active across 1 companies, notably Exelixis, INC.. In total, 4 disclosures have been recorded. Total volume traded: €1.7m. The latest transaction was filed on 13 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
US$142,2723,856 shares@ US$36.89610.0012% mcap16.8% of flow
Common Stock
SEC:0000939767-26-000025·
€142,2723,856 shares@ €36.89610.0012% mcap8.4% of flow
Common Stock
SEC:0000939767-26-000025:0·
US$702,81518,834 shares@ US$37.31630.0061% mcap83.2% of flow
Common Stock
SEC:0000939767-25-000099·
€702,81518,834 shares@ €37.31630.0061% mcap41.6% of flow
Common Stock
SEC:0000939767-25-000099:0·
4 of 4 declarations
About Eckhardt Sue Gail
Eckhardt Sue Gail is a Director at EXELIXIS, INC., a biotechnology company. In her role, she contributes to the strategic direction and oversight of the company's operations. Sue Gail brings significant experience in the sector, thus supporting innovation and growth at EXELIXIS.
